An interventional study of LigaSureTM vessel sealing device in Pelvic Organ Prolapse, sponsored by Marlana McDowell. Completed at 2 sites in United States. Open to female participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-22.
Sponsored by Marlana McDowell · Not applicable, Interventional, and Treatment
This study will investigate pain outcomes for patients undergoing vaginal hysterectomy with pelvic reconstructive surgery using the LigasureTM vessel sealing device as compared to conventional clamping and suturing methods.
516 studies on the registry are indexed under Pelvic Organ Prolapse; 80 are open to participants now.
This study's enrollment of 95 is above the median of 80 across 334 interventional studies indexed under Pelvic Organ Prolapse.
Browse Pelvic Organ Prolapse studies →This is the only study on the registry with Marlana McDowell as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Vessel sealing device to be utilized for vaginal hysterectomy
Device: LigaSureTM vessel sealing device
Vaginal hysterectomy will be performed utilizing conventional Heaney clamps, scissors, and suturing material.
Device will be used to clamp, cauterize, seal, and transect tissue during vaginal hysterectomy.
Also known as: LigaSure, LigaSureTM, Electrosurgical sealing device
Postoperative Pain
Visual Analog Scale, 0-10, with 10 being "most severe pain"
Time frame: 3-6 hours postoperative
Vaginal Pain
Visual Analog Scale, 0-10, with 10 being "most severe pain"
Time frame: 3-6 hours postoperative
Abdominal Pain
Visual Analog Scale, 0-10, with 10 being "most severe pain"
Time frame: 3-6 hours postoperative
Plan to share: No
This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.